WATERTOWN, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics ...
WATERTOWN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results